Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ixabepilone and Cyclophosphamide in HER2-Negative Breast Cancer
NCT00866905Phase 2Completed
- Sponsor
- SCRI Development Innovations
- Start
- Apr 2009
- Primary completion
- Jul 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ixabepilone in breast cancer, sponsored by SCRI Development Innovations. Started Apr 2009; status: completed.
02
Drugs
ixabepilone
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00866905.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00866905.